Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for ...

Primary results from the Phase II ARACOG (AFT-47) trial, a head-to-head randomized trial conducted by Alliance Foundation Trials LLC, showed that patients treated with NUBEQA ® (darolutamide; n=55) ...

More often than not, pulling data from the internet can be a major pain in the behind. It lulls you into a false sense of accomplishment, since downloading a web page is the easy part. But when you ...

Discover the essential techniques for validating and cleaning JSON data, ensuring data integrity and proper formatting for various applications and APIs.

New research shows a novel pill is helping people with advanced pancreatic cancer live longer. It's not a cure, as the drug's effects eventually waned. But it's a very different ...

Recent graduates are struggling in today's job market, with fewer entry-level positions available and more competition than ever — making graduation feel less celebratory and more stressful. Unlike ...